Clinical Trial: Application of Intratumoral Kinetic Heterogeneity Parameters Derived from Dynamic Contrast-Enhanced MRI in the Diagnosis and Management of Breast Diseases (China)

Posted On: 2026-08-24

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Application of Intratumoral Kinetic Heterogeneity Parameters Derived from Dynamic Contrast-Enhanced MRI in the Diagnosis and Management of Breast Diseases'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130654

Registration Time: 2026/08/23

Type: Diagnostic test

Primary Sponsor: Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336103

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Application of Intratumoral Kinetic Heterogeneity Parameters Derived from Dynamic Contrast-Enhanced MRI in the Diagnosis and Management of Breast Diseases (China)